John P. Kenny - 04 Nov 2021 Form 4 Insider Report for MERIDIAN BIOSCIENCE INC (VIVO)

Role: Chief Executive Officer, Director
Signature: /s/ Bryan T. Baldasare as Attorney-in-fact for John P. Kenny
Issuer symbol: VIVO
Transactions as of: 04 Nov 2021
Net transactions value: $0
Form type: 4
Filing time: 08 Nov 2021, 15:06:43 UTC
Next filing: 16 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIVO	Common Stock	Award	$0	+56,472	+27%	$0.000000	265,131	04 Nov 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VIVO	Stock Options (Right to Buy)	Award	$0	+82,940		$0.000000	82,940	04 Nov 2021	Common Stock	82,940	$18.88	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These restricted stock units are awarded under the 2021 Omnibus Award Plan and vest in four equal installments from the date of grant (i.e., vest 25% per year until fully vested on November 4, 2025).
F2	These non-qualified options are awarded under the 2021 Omnibus Award Plan and vest as follows: (i) 25% of the options awarded vest on November 4, 2022; and (ii) the remaining 75% of the options awarded vest pro rata each month from November 4, 2022 through November 4, 2025.